Publication:
The Anthrax Vaccine Immunization Program: History, Controversy and Legal Issues

No Thumbnail Available

Date

2000

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

The Anthrax Vaccine Immunization Program: History, Controversy and Legal Issues (2000 Third Year Paper)

Research Data

Abstract

This paper documents the issues that make the AVIP so controversial. It summarizes the current knowledge about the safety and efficacy of the anthrax vaccine, including the vaccine manufacturer’s history with FDA regulators. It summarizes the analysis that led DoD to balance the risks and benefits of the anthrax vaccine in favor of universal, mandatory vaccination. It includes a description of DoD efforts to achieve successful implementation of the program, as well as the setbacks that have arisen. This collection of observations about the Anthrax Vaccine Immunization Program is relevant for: any attorney prosecuting or defending a member accused of refusing the vaccine; for any servicemember concerned about taking the vaccine; and for member of the general public who wants to know the context of the current controversy.

Description

Other Available Sources

Keywords

Food and Drug Law, AVIP, anthrax

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories